Mark ZiatsJun 10, 20241 min readWSJ Article on Sleep and DietOne of the most common compliants I get it sleep related. Interesting article discussing how diet and dietary choices can impact sleep.To Sleep Better, Change What—and When—You Eat:https://www.wsj.com/health/wellness/sleep-food-eat-time-diet-1e948397?st=3242nk2uq0v0pw5&reflink=article_gmail_share
One of the most common compliants I get it sleep related. Interesting article discussing how diet and dietary choices can impact sleep.To Sleep Better, Change What—and When—You Eat:https://www.wsj.com/health/wellness/sleep-food-eat-time-diet-1e948397?st=3242nk2uq0v0pw5&reflink=article_gmail_share
More legal evolution in the compounding GLP-1 (tirzaperitide / Zepbound) sagaFDA Announced Removal of Tirzepatide from the Drug Shortage List https://search.app/1tgc1KWT5tQ1BPyQA
The evolving landscape for compounded GLP-1 drugsA lawsuit from a compounding trade group in October claimed tirzepatide was still in shortage, forcing the FDA to reassess. FDA says...
WSJ Article on Stopping OzempicMany patients ask me if they have to 'stay on it forever'-- the answer is no but the emerging data suggest their may be some rebound....
Comments